HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib
Titel:
HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib
Auteur:
Tomasevic, Z. Smyth, L.M. Saura, C. Boni, V. Garcia-Sáenz, J.Á. Prat, A. Eli, L. Garza, S.J. Lalani, A.S. Crown, J.P.